Vascular Specialist International

The Korean Society for Vascular Surgery (대한혈관외과학회)
권호 표지
DOI QR코드

DOI QR Code

Predictors for Amputation in Patients with Diabetic Foot Wound

  • Received : 2018.09.26
  • Accepted : 2018.10.26
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Purpose: Diabetic foot wound (DFW) is known as a major contributor of nontraumatic lower extremity amputation. We aimed to evaluate overall amputation rates and risk factors for amputation in patients with DFW. Materials and Methods: From January 2014 to December 2017, 141 patients with DFW were enrolled. We determined rates and risk factors of major amputation in DFW and in DFW with peripheral arterial occlusive disease (PAOD). In addition, we investigated rates and predictors for amputation in diabetic foot ulcer (DFU). Results: The overall rate of major amputation was 26.2% in patients with DFW. Among 141 DFWs, 76 patients (53.9%) had PAOD and 29 patients (38.2%) of 76 DFWs with PAOD underwent major amputation. Wound state according to Wagner classification, congestive heart failure, leukocytosis, dementia, and PAOD were the significant risk factors for major amputation. In DFW with PAOD, Wagner classification grades and leukocytosis were the predictors for major amputation. In addition, amputation was performed for 28 patients (38.4%) while major amputation was performed for 5 patients (6.8%) of 73 DFUs. Only the presence of osteomyelitis (OM) showed significant difference for amputation in DFU. Conclusion: This study represented that approximately a quarter of DFWs underwent major amputation. Moreover, over half of DFW patients had PAOD and about 38.2% of them underwent major amputation. Wound state and PAOD was major predictors for major amputation in DFW. Systemic factors, such as CHF, leukocytosis, and dementia were identified as risk factors for major amputation. In terms of DFU, 38.4% underwent amputation and the presence of OM was a determinant for amputation.

Keywords

References

  1. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91. https://doi.org/10.2337/diacare.6.1.87
  2. Fylling CP, Knighton DR. Amputation in the diabetic population: incidence, causes, cost, treatment, and prevention. J Enterostomal Ther 1989;16:247-255.
  3. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998;176(2A Suppl):5S-10S. https://doi.org/10.1016/S0002-9610(98)00181-0
  4. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993;233:485-491. https://doi.org/10.1111/j.1365-2796.1993.tb01003.x
  5. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008;51:747-755. https://doi.org/10.1007/s00125-008-0940-0
  6. Jonasson JM, Ye W, Sparen P, Apelqvist J, Nyren O, Brismar K. Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 2008;31:1536-1540. https://doi.org/10.2337/dc08-0344
  7. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-3341. https://doi.org/10.2337/diacare.26.12.3333
  8. Gemechu FW, Seemant F, Curley CA. Diabetic foot infections. Am Fam Physician 2013;88:177-184.
  9. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007;50:18-25. https://doi.org/10.1007/s00125-006-0491-1
  10. Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabet Med 1996;13 Suppl 1:S12-16. https://doi.org/10.1002/dme.1996.13.s1.12
  11. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998;21:855-859. https://doi.org/10.2337/diacare.21.5.855
  12. Shojaiefard A, Khorgami Z, Larijani B. Independent risk factors for amputation in diabetic foot. Int J Diabetes Dev Tries 2008;28:32-37. https://doi.org/10.4103/0973-3930.43096
  13. Wagner FW. A classification and treatment program for diabetic, neuropathic, and dysvascular foot problems. Am Acad Orthop Surg Instr Course Lect 1979;28:143-165.
  14. Moss SE, Klein R, Klein BE. The 14-year incidence of lower extremity amputations in a diabetic population. The Wisconsin epidemiologic study of diabetic retinopathy. Diabetes Care 1999;22:951-959. https://doi.org/10.2337/diacare.22.6.951
  15. Miyajima S, Shirai A, Yamamoto S, Okada N, Matsushita T. Risk factors for major limb amputation in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006;71:272-279. https://doi.org/10.1016/j.diabres.2005.07.005
  16. Huang YY, Lin CW, Yang HM, Hung SY, Chen IW. Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene. J Foot Ankle Res 2018. doi: 10.1186/s13047-017-0243-0.
  17. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: the Wagner and the university of Texas wound classification systems. Diabetes Care 2001;24:84-88. https://doi.org/10.2337/diacare.24.1.84
  18. Calhoun JH, Cantrell J, Cobos J, Lacy J, Valdez RR, Hokanson J, et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 1988;9:101-106. https://doi.org/10.1177/107110078800900301
  19. Lenselink E, Holloway S, Eefting D. Outcomes after foot surger y in people with a diabetic foot ulcer and a 12-month follow-up. J Wound Care 2017;26:218-227. https://doi.org/10.12968/jowc.2017.26.5.218
  20. Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016;63(2 Suppl):3S-21S. https://doi.org/10.1016/j.jvs.2015.10.003
  21. Claesson K, Kolbel T, Acosta S. Role of endovascular intervention in patients with diabetic foot ulcer and concomitant peripheral arterial disease. Int Angiol 2011;30:349-358.
  22. Otte J, van Netten JJ, Woittiez AJ. The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation. J Vasc Surg 2015;62:406-411. https://doi.org/10.1016/j.jvs.2015.02.051
  23. He Y, Qian H, Xu L, Zhang S, Gu X, Gu J, et al. Association between estimated glomerular filtration rate and outcomes in patients with diabetic foot ulcers: a 3-year follow-up study. Eur J Endocrinol 2017;177:41-50. https://doi.org/10.1530/EJE-17-0070
  24. Pemayun TG, Naibaho RM, Novitasari D, Amin N, Minuljo TT. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a hospital-based case-control study. Diabet Foot Ankle 2015. doi: 10.3402/dfa.v6.29629.
  25. Yesil S, Akinci B, Yener S, Bayraktar F, Karabay O, Havitcioglu H, et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens) 2009;8:286-295. https://doi.org/10.14310/horm.2002.1245

Cited by

  1. A clinical study of risk factors associated with amputation in diabetic foot disease patients attending a tertiary care hospital in a rural setting vol.6, pp.1, 2020, https://doi.org/10.4103/jcrsm.jcrsm_13_20
  2. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A meta-analysis vol.15, pp.9, 2018, https://doi.org/10.1371/journal.pone.0239236
  3. Impact of repeated remote ischemic conditioning on diabetic foot ulcers: A proof‐of‐concept study vol.29, pp.5, 2018, https://doi.org/10.1111/wrr.12956
  4. Biomechanical modelling of diabetic foot ulcers: A computational study vol.127, pp.None, 2018, https://doi.org/10.1016/j.jbiomech.2021.110699
  5. Predictors and outcomes of diabetic foot ulcer infection with ESBL-producing bacteria in a large tertiary center vol.113, pp.None, 2018, https://doi.org/10.1016/j.ijid.2021.10.016